"Revision Revolution" .. New antibodies increase human immunity from flu

A US study reveals a new vaccine based on a mixture of three antibodies targeting virus protein instead of its enzymes, which increases human immunity to the flu. Technology increases immunity without preventing infection directly, but it reduces symptoms and is one of the need for renewable seasonal vaccines. The success of clinical trials can open the door for innovative treatments for other viruses.